    <SEC-DOCUMENT>0001437749-25-013863-index.html : 20250430
    <SEC-HEADER>0001437749-25-013863.hdr.sgml : 20250430
    <ACCEPTANCE-DATETIME>20250430162004
    ACCESSION NUMBER:		0001437749-25-013863
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20241231
    FILED AS OF DATE:		20250430
    DATE AS OF CHANGE:		20250430
    EFFECTIVENESS DATE:		20250430

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			TG THERAPEUTICS, INC.
    		CENTRAL INDEX KEY:			0001001316
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				363898269
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-32639
    		FILM NUMBER:		25895697

    	BUSINESS ADDRESS:
    		STREET 1:		2 GANSEVOORT STREET, 9TH FLOOR
    		CITY:			NEW YORK
    		STATE:			NY
    		ZIP:			10014
    		BUSINESS PHONE:		(212) 554-4484

    	MAIL ADDRESS:
    		STREET 1:		2 GANSEVOORT STREET, 9TH FLOOR
    		CITY:			NEW YORK
    		STATE:			NY
    		ZIP:			10014

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	MANHATTAN PHARMACEUTICALS INC
    		DATE OF NAME CHANGE:	20030310

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	ATLANTIC TECHNOLOGY VENTURES INC
    		DATE OF NAME CHANGE:	20000330

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	ATLANTIC PHARMACEUTICALS INC
    		DATE OF NAME CHANGE:	19960703
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>tgtars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: tgtars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>